These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23826794)

  • 1. The clinical significance of hypogammaglobulinaemia and serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukaemia (CLL).
    Best OG; Crassini K; Freeman JA; Mulligan SP;
    Scand J Infect Dis; 2013 Sep; 45(9):729. PubMed ID: 23826794
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.
    Svensson T; Höglund M; Cherif H
    Scand J Infect Dis; 2013 Jul; 45(7):537-42. PubMed ID: 23427875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases".
    Svensson T; Cherif H; Höglund M
    Scand J Infect Dis; 2013 Sep; 45(9):730. PubMed ID: 23848410
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immune globulin in chronic lymphocytic leukaemia.
    Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin.
    Jurlander J; Geisler CH; Hansen MM
    Eur J Haematol; 1994 Aug; 53(2):114-8. PubMed ID: 8088382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
    Boughton BJ; Jackson N; Lim S; Smith N
    Clin Lab Haematol; 1995 Mar; 17(1):75-80. PubMed ID: 7621634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlations between secondary hypogammaglobulinaemia, infections and mortality and the need for preventive immunoglobulin replacement in patients with chronic lymphoid leukaemia].
    Losonczy H; Nagy Á; Kosztolányi S; Tóth O; Csalódi R; Hussain A; Szomor Á
    Orv Hetil; 2019 Sep; 160(38):1487-1494. PubMed ID: 31537095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia.
    Lacombe C; Gombert J; Dreyfus B; Brizard A; Preud'Homme JL
    Clin Immunol; 1999 Jan; 90(1):128-32. PubMed ID: 9884361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia.
    Crassini KR; Zhang E; Balendran S; Freeman JA; Best OG; Forsyth CJ; Mackinlay NJ; Han P; Stevenson WS; Mulligan SP
    Br J Haematol; 2018 Apr; 181(1):97-101. PubMed ID: 29468645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern of hypogammaglobulinaemia in Sri Lankan children.
    de Silva NR; Gunawardena S; Ratnayake H; Weerasinghe A
    Ceylon Med J; 2000 Jun; 45(2):58-60. PubMed ID: 11051701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia.
    Reda G; Cassin R; Gentile M; Mauro FR; Giannarelli D; Fattizzo B; Barbieri M; Silvestris I; Fabris S; Morabito F; Neri A; Barcellini W; Cortelezzi A
    Leukemia; 2019 Jun; 33(6):1519-1522. PubMed ID: 30635629
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
    Keegan A; Dennington PM; Dhondy N; Mulligan SP
    Eur J Haematol; 2022 Jun; 108(6):460-468. PubMed ID: 35152500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.
    Hensel M; Kornacker M; Yammeni S; Egerer G; Ho AD
    Br J Haematol; 2003 Aug; 122(4):600-6. PubMed ID: 12899715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypogammaglobulinaemia and immunoglobulin deficiencies in chronic lymphocytic leukaemia.
    Krcová I; Faltýnek L; Krc I
    Acta Univ Palacki Olomuc Fac Med; 1986; 113():149-55. PubMed ID: 2941979
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypogammaglobulinemia in heart failure patients: prevalence and impact on infectious outcomes.
    Yamani MH; Narayan SB; Haire C; Hobbs R
    J Heart Lung Transplant; 2007 Dec; 26(12):1350-1. PubMed ID: 18096494
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia.
    Mauro FR; Morabito F; Vincelli ID; Petrucci L; Campanelli M; Salaroli A; Uccello G; Petrungaro A; Ronco F; Raponi S; Nanni M; Neri A; Ferrarini M; Guarini AR; Foà R; Gentile M
    Leuk Res; 2017 Jun; 57():65-71. PubMed ID: 28292720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case 22-2005: intravenous immune globulin in chronic lymphocytic leukemia.
    Newcom SR
    N Engl J Med; 2005 Oct; 353(17):1862-3; author reply 1862-3. PubMed ID: 16251548
    [No Abstract]   [Full Text] [Related]  

  • 18. Surface phenotype and immunoglobulin levels in B-cell chronic lymphocytic leukaemia.
    Orfao A; Gonzalez M; San Miguel JF; Tomas JF; Canizo MC; Lopez-Berges MC; Moraleda JM; Lopez Borrasca A
    Haematologia (Budap); 1990; 23(1):49-56. PubMed ID: 2397923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
    Dhalla F; Lucas M; Schuh A; Bhole M; Jain R; Patel SY; Misbah S; Chapel H
    J Clin Immunol; 2014 Apr; 34(3):277-82. PubMed ID: 24557494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
    Chapel H; Griffiths H; Brennan V; Bunch C; Lea J; Lee M
    Immunol Invest; 1991 Apr; 20(2):187-91. PubMed ID: 1864637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.